GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Chemcrux Enterprises Ltd

Chemcrux Enterprises Q2 FY27 Standalone Net Profit at INR 162.42 Lacs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Nov 2026, 06:32 PM IST  ·  BSE ID: 5d5ec055-bced-4371-9da1-7c750367fc81
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its latest financial results, showing an increase in net profit for the quarter ending September 2026.
🤖 AI Summary
  • Standalone net profit for Chemcrux Enterprises reached INR 162.42 Lacs in Q2 FY27.
  • Revenue from operations was INR 2,384.30 Lacs for the quarter ended 30th September 2026.
  • The Board approved unaudited standalone and consolidated financial results on November 2, 2026.
  • A corrected Limited Review Report was submitted, revising the reporting period to 30th September 2026.
  • Basic Earnings Per Share (EPS) for Q2 FY27 stood at Rs. 1.10.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
2,384.30 INR Lacs
28.52%
Net Profit for the period (Q2 FY27)
162.42 INR Lacs
103.15%
Total Income (Q2 FY27)
2,414.94 INR Lacs
24.79%
Basic EPS (Q2 FY27)
1.10 Rs.
103.70%
Total Assets (as at 30-09-2026)
12,387.46 INR Lacs
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations to INR 2,384.30 Lacs for Q2 FY27 indicates continued sales activity in the manufacturing and processing of Bulk Drug Intermediates.
💰
Financial Impact
Net profit for Q2 FY27 increased to INR 162.42 Lacs, contributing to a half-year profit of INR 299.85 Lacs, improving the company's earnings.
⚙️
Operational Impact
The company granted 1,07,700 Employee Stock Options in the previous quarter, impacting employee benefits expense, with the final valuation report pending.
⚠️
Risk Impact
The reliance on management's estimated valuation for ESOPs, pending an independent valuation report, introduces a minor accounting risk, though management states adjustments are not expected to be material.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as the company's financial performance influences the intrinsic value of their holdings through reported earnings and revenue growth.
🔍
Management Signal
The Board's approval and timely disclosure of financial results, including a corrected report, signal adherence to regulatory compliance and transparent reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — assess sustained revenue and profit growth.
Receipt of final ESOP valuation report — verify any material adjustments.
Updates on new labor codes impact — monitor for any operational changes.
LOW RISK The filing notes pending final valuation for ESOPs, but management anticipates no material adjustments.
💡 Investor Takeaway
Chemcrux Enterprises reported a standalone net profit of INR 162.42 Lacs for Q2 FY27, a 103.15% increase from INR 79.95 Lacs in Q2 FY26. Revenue from operations for the quarter stood at INR 2,384.30 Lacs, up 28.52% YoY, indicating growth in core business activities.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 standalone net profit of INR 162.42 Lacs shows a substantial increase from INR 79.95 Lacs in Q2 FY26.
  • Revenue from operations grew to INR 2,384.30 Lacs in Q2 FY27 from INR 1,855.31 Lacs in Q2 FY26.

⚠️ Concerns

  • Other income for Q2 FY27 was INR 30.63 Lacs, a decrease from INR 79.81 Lacs in Q2 FY26.
  • The company's Limited Review Report noted that ESOP valuation is based on management estimates, with final fair value pending an independent valuer.
📅 Company Track Record
Chemcrux Enterprises has shown consistent growth in recent quarters, with Q1 FY27 standalone profit up 135.12% YoY to INR 137.43 Lacs, following a 103.15% YoY increase in Q2 FY27 net profit.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Chemcrux Enterprises' standalone net profit for Q2 FY27?
Chemcrux Enterprises reported a standalone net profit of INR 162.42 Lacs for the quarter ended 30th September 2026 (Q2 FY27), increasing from INR 79.95 Lacs in Q2 FY26.
What was the revenue from operations for Chemcrux Enterprises in Q2 FY27?
Revenue from operations for Chemcrux Enterprises was INR 2,384.30 Lacs for the quarter ended 30th September 2026 (Q2 FY27).
What is the Basic Earnings Per Share (EPS) for Chemcrux Enterprises in Q2 FY27?
The Basic Earnings Per Share (EPS) for Chemcrux Enterprises in Q2 FY27 is Rs. 1.10, compared to Rs. 0.54 in Q2 FY26.
What was the total income for Chemcrux Enterprises in Q2 FY27?
The total income for Chemcrux Enterprises in Q2 FY27 was INR 2,414.94 Lacs, up from INR 1,935.12 Lacs in Q2 FY26.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.